182 related articles for article (PubMed ID: 23695389)
1. Estrogen receptor 1 gene as a tumor suppressor gene in hepatocellular carcinoma detected by triple-combination array analysis.
Hishida M; Nomoto S; Inokawa Y; Hayashi M; Kanda M; Okamura Y; Nishikawa Y; Tanaka C; Kobayashi D; Yamada S; Nakayama G; Fujii T; Sugimoto H; Koike M; Fujiwara M; Takeda S; Kodera Y
Int J Oncol; 2013 Jul; 43(1):88-94. PubMed ID: 23695389
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine kinase 7: a hepatocellular carcinoma-related gene detected by triple-combination array.
Hishida M; Inokawa Y; Takano N; Nishikawa Y; Iwata N; Kanda M; Tanaka C; Kobayashi D; Yamada S; Nakayama G; Fujii T; Sugimoto H; Koike M; Fujiwara M; Kodera Y; Nomoto S
J Surg Res; 2015 May; 195(2):444-53. PubMed ID: 25796105
[TBL] [Abstract][Full Text] [Related]
3. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
[TBL] [Abstract][Full Text] [Related]
4. Detection of doublecortin domain-containing 2 (DCDC2), a new candidate tumor suppressor gene of hepatocellular carcinoma, by triple combination array analysis.
Inokawa Y; Nomoto S; Hishida M; Hayashi M; Kanda M; Nishikawa Y; Takeda S; Sugimoto H; Fujii T; Yamada S; Kodera Y
J Exp Clin Cancer Res; 2013 Sep; 32(1):65. PubMed ID: 24034596
[TBL] [Abstract][Full Text] [Related]
5. CCNJ detected by triple combination array analysis as a tumor-related gene of hepatocellular carcinoma.
Takano N; Hishida M; Inokawa Y; Hayashi M; Kanda M; Nishikawa Y; Iwata N; Kobayashi D; Tanaka C; Yamada S; Nakayama G; Fujii T; Sugimoto H; Koike M; Fujiwara M; Kodera Y; Nomoto S
Int J Oncol; 2015 May; 46(5):1963-70. PubMed ID: 25672416
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
7. Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array.
Okamura Y; Nomoto S; Kanda M; Li Q; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
Cancer Lett; 2010 Mar; 289(2):170-7. PubMed ID: 19733004
[TBL] [Abstract][Full Text] [Related]
8. Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis.
Kanda M; Nomoto S; Okamura Y; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
Int J Oncol; 2009 Sep; 35(3):477-83. PubMed ID: 19639168
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.
Revill K; Wang T; Lachenmayer A; Kojima K; Harrington A; Li J; Hoshida Y; Llovet JM; Powers S
Gastroenterology; 2013 Dec; 145(6):1424-35.e1-25. PubMed ID: 24012984
[TBL] [Abstract][Full Text] [Related]
10. Identification of the bleomycin hydrolase gene as a methylated tumor suppressor gene in hepatocellular carcinoma using a novel triple-combination array method.
Okamura Y; Nomoto S; Hayashi M; Hishida M; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y; Nakao A
Cancer Lett; 2011 Dec; 312(2):150-7. PubMed ID: 21943823
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of reelin (RELN) gene is associated with high recurrence rate of hepatocellular carcinoma.
Okamura Y; Nomoto S; Kanda M; Hayashi M; Nishikawa Y; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2011 Feb; 18(2):572-9. PubMed ID: 20734148
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma.
Kanda M; Nomoto S; Okamura Y; Hayashi M; Hishida M; Fujii T; Nishikawa Y; Sugimoto H; Takeda S; Nakao A
Mol Carcinog; 2011 Aug; 50(8):571-9. PubMed ID: 21268132
[TBL] [Abstract][Full Text] [Related]
13. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
[TBL] [Abstract][Full Text] [Related]
14. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma.
Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Hishida M; Suenaga M; Yamada S; Inokawa Y; Nishikawa Y; Asai M; Fujii T; Sugimoto H; Kodera Y
Int J Oncol; 2014 Jan; 44(1):44-52. PubMed ID: 24189587
[TBL] [Abstract][Full Text] [Related]
16. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide DNA methylation analysis in hepatocellular carcinoma.
Yamada N; Yasui K; Dohi O; Gen Y; Tomie A; Kitaichi T; Iwai N; Mitsuyoshi H; Sumida Y; Moriguchi M; Yamaguchi K; Nishikawa T; Umemura A; Naito Y; Tanaka S; Arii S; Itoh Y
Oncol Rep; 2016 Apr; 35(4):2228-36. PubMed ID: 26883180
[TBL] [Abstract][Full Text] [Related]
19. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
[TBL] [Abstract][Full Text] [Related]
20. Dynamin 3: a new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis.
Inokawa Y; Nomoto S; Hishida M; Hayashi M; Kanda M; Nishikawa Y; Takeda S; Fujiwara M; Koike M; Sugimoto H; Fujii T; Nakayama G; Yamada S; Tanaka C; Kobayashi D; Kodera Y
Onco Targets Ther; 2013; 6():1417-24. PubMed ID: 24143113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
